lcms

(3)
Company
Gutenberg Technology
Saas · Education · Ai

Gutenberg Technology

Gutenberg Technology is a Franco-American B2B SaaS company that builds an end-to-end Learning Content Management System (LCMS) and AI-powered authoring tools. Its MobileFirst platform lets publishers, universities, and enterprises author, transform, reuse, and distribute print and digital learning content from a single workflow. Trusted by names like Cengage, National Geographic Learning, Vista Higher Learning, and CompTIA, the platform has powered 230,000+ learning assets reaching 7+ million learners, and in 2025 launched an AI Course Builder that converts existing documents into structured eLearning modules.

lcms · learning-content-management-systemRead →
Legend
Gjergj Demiraj
Executive · Operator · Founder

Gjergj Demiraj

Gjergj Demiraj is the President and CEO of Gutenberg Technology, a Boston-based edtech company whose end-to-end content management platform helps publishers and enterprises author, reuse, and distribute learning content at scale. A polyglot with an international consulting background in finance, telecom, and media, he joined the company in 2012, opened its US office in Boston in 2016, and took the top job in 2019 after helping shape the business across every department. He co-founded the French crowdfunding platform Anaxago and earlier advised global publishing groups on digital transformation at EidosMedia in Milan and Paris.

edtech · digital-publishingRead →
Company
InterVenn Biosciences
Health · Ai · Enterprise

InterVenn Biosciences

InterVenn Biosciences is a South San Francisco biotech building an AI-driven glycoproteomics platform that reads the sugar coatings on proteins to detect disease earlier. Its flagship blood test, GlycoKnow Ovarian, distinguishes ovarian cancer from benign pelvic masses with ~86% accuracy and went commercial in 2025. Founded in 2017 by Aldo Carrascoso with chemists Carolyn Bertozzi (Nobel Laureate) and Carlito Lebrilla, the company has raised roughly $244M, including a $201M Series C led by SoftBank in 2021.

glycoproteomics · liquid-biopsyRead →